investors
With a rapidly growing business in Europe and plans for a future launch in the US, Sedana Medical is well-positioned for the future.
We are well on the way to our vision of making inhaled sedation a standard therapy in critical care.
- Mikael Haag
-
CFO AND HEAD OF INVESTOR RELATIONS
- ir@sedanamedical.com
The Share
Press Releases
2026
2026-07-17 07:00
NDA submission and improved EBITDA Second quarter 2026 January-June 2026 CEO comments NDA submission and improved EBITDA We submitted our New Drug Application...
2026-07-03 13:00
Sedana Medical AB (publ) plans to present its interim report for the second quarter of 2026 on Friday July 17 at 13:30 CET. According to the financial...
2026-06-17 08:00
Sedana Medical AB (publ) today announces that Mikael Haag takes office as Chief Financial Officer (CFO) and member of the Executive Management Team, effective...
Financial Reports
Financial Calendar
Latest Presentation
No presentations found.
